Alyvant uses de-identified patient-level analytics to better understand the nuances of a disease, patterns of physician prescribing, and payer reimbursement. We then turn insights into action through our fit-for-purpose commercial pharmaceutical organization. Our long-range vision is to use technology to reduce the cost of commercializing all medicines, thereby generating savings for the healthcare system at large and helping to ensure that every patient who might benefit from an approved therapy has the opportunity to speak with a physician about appropriate treatment options.
Company Details
- Founded
- -
- Address
- 135 5th Ave,
- in****@****ant.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- alyvant.com
- Keywords
- Pharmaceuticals, Commercialization, Technology, Sales Force Optimization, Co-Promotion, Digital Deployment, Agile Commercial Platform, Patient Finding, Physician Activation.
- HQ
- New York, New York
Alyvant, Inc. Questions
Alyvant, Inc.'s website is alyvant.com
Alyvant, Inc.'s LinkedIn profile is https://www.linkedin.com/company/alyvant
Alyvant, Inc.'s industry is
Pharmaceutical Manufacturing
Alyvant, Inc.'s top competitors are
Locust Walk,
Vayo (Acquired By Gong),
Flying Manta,
Roivant,
Databricks,
Data360 For Healthcare Engagement,
Tradertools Inc.,
X-Biotix Therapeutics, Inc.,
Avillion Life Sciences,
Acurist.ai.
Alyvant, Inc.'s support email address is info@alyvant.com
Alyvant, Inc.'s categories are Pharmaceutical Manufacturing
Alyvant, Inc.'s founding year is 2018
